Key facts
- Notable investors include Bluepoint.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zetrone
- ·The full record, as it builds
Funding rounds
No funding rounds for Zetrone are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zetrone
Developer of an AI-driven biotechnology platform designed to revolutionize sustainable bioresource utilization and energy transformation. The company offers an integrated service combining low-temperature plasma technology, synthetic biology and AI to convert underutilized organic waste into efficiency bioresources, enabling customers to overcome global supply shortages and achieve sustainable energy independence.
- Sector
- Healthcare
- HQ
- Hwaseong, South Korea
- Founded
- 2025
- Website
- zetrone.com/
- Ownership
- Privately Held (backing)
Zetrone doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zetrone shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zetrone in its N-PORT filings yet. We sweep new filings monthly.